Rapid antigen tests arriving in countries to assist in COVID-19 response in the Americas


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Rapid antigen tests arriving in countries to assist in COVID-19 response in the Americas
The Pan American Health Organization has deployed 190,000 new COVID-19 antigen diagnostic tests donated to four countries in Latin America and the Caribbean and is conducting training to implement pilot testing of their operation.

The Pan American Health Organization has deployed 190,000 new COVID-19 antigen diagnostic tests donated to four countries in Latin America and the Caribbean and is conducting training to implement pilot testing of their operation. 

From its logistics stock in Panama, PAHO shipped 80,000 tests to Ecuador, 40,000 to El Salvador, 40,000 to Honduras—to facilitate diagnostics after the passage of Tropical Storm Eta- and 30,000 tests to Suriname.  In addition, PAHO is training staff to carry out pilot testing for implementation in Ecuador, El Salvador, Suriname, and Mexico, which is receiving tests through WHO. 

These new tests, recently approved by WHO, could transform the region’s COVID-19 response by allowing health workers to undertake accurate, rapid testing for symptomatic patients, even in remote communities. 

Rapid antigen tests are more accurate in determining if someone is currently infected, unlike  previous rapid, antibody tests, which can show when someone has had COVID-19 but often give a negative result during the early stages of infection. 

PAHO is assisting countries to implement new testing protocols to ensure that health workers know how to use the new diagnostics and report their results. 

Consultations and training on implementation of the COVID-19 antigen-based rapid diagnostic test are being undertaken in Jamaica and Venezuela, as well as in Honduras, Costa Rica, and Trinidad and Tobago. 

“By providing results quickly, the new test will empower frontline health workers to better manage cases by isolating patients to prevent further spread and to begin treatment immediately,” PAHO Director Carissa F. Etienne said recently. “If distributed widely, this new test will transform our COVID response.” She added that these diagnostic tests will be particularly useful in hard to reach areas, which have been disproportionally impacted by the pandemic and which are without easy access to a laboratory. 

PAHO’s Strategic Fund, a regional technical cooperation mechanism for pooled procurement of essential medicines and health supplies, is working with the countries to facilitate access to these diagnostic tests. 

PCR diagnostic tests, which are highly accurate and must be conducted in laboratory settings remain the gold standard for testing, even though the time for receipt of their results is more delayed as compared with the rapid tests.  Antigen detection tests do not replace PCR but complement the molecular detection, according to PAHO.

Antigen based detection should be prioritized for mild or ambulatory suspected cases, and eventually for contacts of confirmed patients in close settings. Their use in other types of processes such as at ports of entry or in searching for asymptomatic cases is not currently recommended by PAHO. 

These tests form part of the WHO Access to COVID-19 Tools (ACT) Accelerator to develop, procure, and distribute critical new tools to fight the pandemic. 

Tags : #Rapidantigentests #COVID-19 #PAHO #CarissaFEtienne #frontlinehealthworkers #WHO #Covid19Infection

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026